Navigation Links
In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression

SAN DIEGO, California, 23 May 2007 - The antidepressant duloxetine hydrochloride was equally effective in reducing painful symptoms in depressed patients who did not respond, or responded only partially, to treatment with a selective serotonin reuptake inhibitor (SSRI), regardless of whether those patients were switched from an SSRI abruptly or gradually.1 This new data was presented today at the American Psychiatric Association’s 160th Annual Meeting in San Diego, Calif.

Between 30-50 percent of individuals treated with a given antidepressant do not respond to that treatment.2,3 As a result, physicians often need to switch patients from one antidepressant to another. Although this is a common clinical scenario, there are relatively few published studies to guide physicians on how to switch patients from one antidepressant to another.

“Recent data suggests the more antidepressants an individual has tried, the less likely they are to benefit from a new antidepressant.4 Therefore it is important to maximise the chance of remission earlier in the treatment pathway,” said Prof. Angel L. Montejo, Psychiatry Research Coordinator, University Hospital of Salamanca, Spain. “These results demonstrate that a switch to duloxetine results in a significant decrease in the painful symptoms in patients with depression and was well tolerated regardless of the switch method used.”

The new results are based on several secondary endpoints from a study comparing the efficacy, safety and tolerability of two switch methods in 368 patients who remained depressed despite taking an SSRI for at least six weeks.5 Participants were randomized to either abrupt discontinuation of their SSRI (the Direct Switch, or DS group) or to a gradual/tapered discontinuation of their SSRI (the Start-Taper Switch, or STS group). Both groups began taking duloxetine 60 mg/day at the beginni
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. In New Study, Duloxetine Reduced Non-specific Pain and Emotional Symptoms Associated with Depression
2. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
3. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
4. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
7. The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. New Study Confirms Role for Pertussis Immunization of Entire Family in Reducing Infant Pertussis
10. Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in Their Phase 2 Clinical Trial
11. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
Post Your Comments:
(Date:10/20/2014)... VIEW, California , 20 de octubre de ... líder en el campo de la pulmonología intervencional, ... su Estudio RENEW, casi 3 meses antes de ... fundamental de exención de dispositivo de investigación (IDE) ... Medicamentos) para el sistema de espiral de reducción ...
(Date:10/20/2014)... 2014  ResMed (NYSE: RMD ) ... Exchange program, a comprehensive suite of software and ... other health care providers. ResMed ... patient information. It integrates valuable sleep and respiratory ... management platforms with customers, in-house or third-party electronic ...
(Date:10/20/2014)... SAN DIEGO , Oct. 20, 2014 /PRNewswire/ ... development of therapeutic antibodies, today announced the appointment ... Development Officer. Dr. Londei will lead the preclinical ... "We are pleased to welcome ... Hamza Suria , President and Chief Executive ...
Breaking Medicine Technology:PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2
... 16, 2011 InspireMD, Inc. (OTC BB: NSPR) ... mesh protective stent system, today announced that it has ... 30, 2011 with the U.S. Securities and Exchange Commission. The ... Year-to-Date Highlights Year-to-date shipment volumes ...
... 2011 Beacon Enterprise Solutions Group, Inc. (OTC ... leader in the design, implementation and management of ... today announces the award from teaming partner ICS ... leading provider of innovative technologies and solutions, to ...
Cached Medicine Technology:InspireMD Provides Mid-Year Strategic Update 2InspireMD Provides Mid-Year Strategic Update 3InspireMD Provides Mid-Year Strategic Update 4InspireMD Provides Mid-Year Strategic Update 5InspireMD Provides Mid-Year Strategic Update 6InspireMD Provides Mid-Year Strategic Update 7Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veteran's Administration 2Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veteran's Administration 3
(Date:10/22/2014)... Two sisters in high school have developed ways to ... Krishen use electronic stethoscopes, which electronically amplify body sounds, ... or heartbeats. Ilina, a senior at Port Huron ... way to detect early lung damage in people exposed ... recorded one breath cycle each from 16 smokers, 25 ...
(Date:10/22/2014)... Maureen Salamon HealthDay ... A crucial part of conventional in vitro fertilization (IVF) -- ... instead take place in a device inside the vagina, new ... contend that the device, called an INVOcell, might sharply cut ... also make the technology more accessible to those who don,t ...
(Date:10/22/2014)... HealthDay Reporter , MONDAY, Oct. 20, 2014 (HealthDay ... for health workers treating Ebola patients, now requiring full body ... at all times. The U.S. Centers for Disease Control ... Dallas nurses contracted Ebola while caring for the first ... Duncan. Nina Pham is currently being treated for her infection ...
(Date:10/20/2014)... Texas (PRWEB) October 20, 2014 The ... the must-have source of thousands of facts, figures and ... countries and 68 medical sector forecast categories the ... with global, regional and national views on the worldwide ... outlook. , The report gives you data for 2010-2019, ...
(Date:10/20/2014)... 2014 Allegheny General Hospital’s (AGH) Cardiovascular ... physicians to repair a damaged mitral valve as the ... system, developed by Abbott Vascular , is designed ... life-threatening condition in which the heart’s mitral valve leaflets ... from the heart’s left ventricle into the left atrium. ...
Breaking Medicine News(10 mins):Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
... WEDNESDAY, Nov. 16 (HealthDay News) -- Broken heart syndrome -- ... emotional stress -- occurs overwhelmingly in women compared to men, ... death of a loved one, a frightening medical diagnosis, a ... 7.5 times more common in females, and women older than ...
... Orange, NJ. Nov. 15, 2011. John DeLuca, PhD, ... on the use of a behavioral technique for cognitive ... investigator was Nancy Chiaravalloti, PhD, director of the Neuropsychology ... on modified Story Memory Technique was made on October ...
... Calif. Tumors can grow for 10 years or longer ... mathematical model developed by Stanford University School of Medicine scientists ... is broadly applicable across all solid tumor types, will be ... "The study,s results can be viewed as both bad ...
... Nov. 16 (HealthDay News) -- ,Losing weight appears to help ... 31 obese people who underwent treatment for gum disease. Half ... had gastric bypass weight loss surgery and also had fat ... of 35) did not have gastric bypass surgery or fat ...
... the emerging field of nanomedicine a breathtaking technological revolution ... diseases? Or does it portend the release of dangerous ... in the body? A new review of more than ... is likely. It appears in ACS, journal Molecular ...
... A study of burn patients has found that those who ... and spent more time on ventilators and in intensive care. ... Stritch School of Medicine, is published ahead of print in ... first to show that the severity of smoke-inhalation injury may ...
Cached Medicine News:Health News:Women More Prone to 'Broken Heart' Syndrome: Study 2Health News:Women More Prone to 'Broken Heart' Syndrome: Study 3Health News:New Stanford model establishes guidelines for earlier cancer detection 2Health News:New Stanford model establishes guidelines for earlier cancer detection 3Health News:New Stanford model establishes guidelines for earlier cancer detection 4Health News:Study documents toll of smoke inhalation injuries 2
Unipolar Ventricular Lead...
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
Steroid-eluting, screw-in pacing lead...
... The Physique leads are small profile ... active-fixation helix. With a lead body size ... tip size of 7 F, the Physique ... lead available today. Available in both straight ...
Medicine Products: